Fig. 1From: Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patientsPreferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flow diagramBack to article page